Salix Pharmaceutical's (SLXP +1.4%) moves up after the FDA approves Fulyzaq to relieve symptoms...

|About: Salix Pharmaceuticals, Ltd. (SLXP)|By:, SA News Editor

Salix Pharmaceutical's (SLXP +1.4%) moves up after the FDA approves Fulyzaq to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy. The drug, which is the first of its kind to relieve diarrhea in AIDS patients and is a common reason why patients discontinue or switch their antiretroviral therapies, is distributed by SLXP under license from Napo Pharmaceuticals.